De­spite de­lay, KalVista wins FDA ap­proval af­ter Makary's short-lived at­tempt to in­ter­vene

The FDA has ap­proved KalVista Phar­ma­ceu­ti­cals’ drug for a rare swelling dis­ease, the com­pa­ny an­nounced on Mon­day, in a key win …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.